Abbott Laboratories (ABT) Institutional Ownership
13F filers reported holding 81.0% of Abbott Laboratories (ABT) shares as of Jun 30, 2026, across 3,009 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 81.0%
- Jun 30, 2026
- 13F filers
- 3,009
- quarter ended Jun 30, 2026
- 13F value
- $127.4B
- 1.4B shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Disposed · Open-market sale | 3,500Common shares without par value | $116.00 | ↗ |
| Sep 30, 2026 | Stratton John G | director | Acquired · Grant / award | 397Stock Equivalent Units | $98.83 | ↗ |
| Sep 30, 2026 | Gonzalez Patricia P. | director | Acquired · Grant / award | 333Stock Equivalent Units | $98.83 | ↗ |
| Sep 30, 2026 | Conroy Kevin T | director | Acquired · Grant / award | 318Stock Equivalent Units | $98.83 | ↗ |
| Sep 30, 2026 | Ahuja Nita | director | Acquired · Grant / award | 318Stock Equivalent Units | $98.83 | ↗ |
| Sep 30, 2026 | Roman Michael F | director | Acquired · Grant / award | 381Stock Equivalent Units | $98.83 | ↗ |
| Sep 2, 2026 | MCCOY JOHN A. | VICE PRESIDENT AND CONTROLLER | Disposed · Open-market sale | 27Common shares without par value | $109.54 | ↗ |
| Sep 1, 2026 | Boudreau Philip P | EVP AND CFO | Disposed · Tax withholding | 388Common shares without par value | $110.36 | ↗ |
| Sep 1, 2026 | MCCOY JOHN A. | VICE PRESIDENT AND CONTROLLER | Disposed · Tax withholding | 52Common shares without par value | $110.36 | ↗ |
| Aug 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | Acquired · Option exercise | 151,869Common shares without par value | $44.40 | ↗ |
| Aug 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | Acquired · Option exercise | 246,963Common shares without par value | $59.94 | ↗ |
| Aug 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | Disposed · Open-market sale | 218,535Common shares without par value | $115.57 | ↗ |
| Aug 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | Disposed · Open-market sale | 180,297Common shares without par value | $116.19 | ↗ |
| Aug 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | Disposed · Option exercise | 151,869Option (right to buy) | — | ↗ |
| Aug 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | Disposed · Option exercise | 246,963Option (right to buy) | — | ↗ |
| Aug 12, 2026 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Disposed · Discretionary | 12Common shares without par value | $107.99 | ↗ |
| Aug 11, 2026 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Disposed · Open-market sale | 5,850Common shares without par value | $109.83 | ↗ |
| Jun 30, 2026 | Ahuja Nita | director | Acquired · Grant / award | 347Stock Equivalent Units | $90.74 | ↗ |
| Jun 30, 2026 | Gonzalez Patricia P. | director | Acquired · Grant / award | 363Stock Equivalent Units | $90.74 | ↗ |
| Jun 30, 2026 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Disposed · Tax withholding | 269Common shares without par value | $92.71 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Abbott Laboratories do institutions hold?
13F filers reported holding 81.0% of Abbott Laboratories' shares as of Jun 30, 2026, across 3,009 filers.
How many 13F filers hold Abbott Laboratories?
Abbott Laboratories was held by 3,009 13F filers as of Jun 30, 2026.
Not investment advice.

